MIRACLE

  • .
    Photo
    Boris Zimmermann

Mid-infrared arthroscopy innovative imaging system for real-time clinical in depth examination and diagnosis of degenerative joint diseases

MIRACLE will take towards commercialisation the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage enabling early diagnosis of degenerative joint diseases such as osteoarthritis.

MIRACLE

 

European Commision - H2020 ICT-30-2017 - Photonics KET 2017


Project number: 780598
Period covered - start date: 1/1/2018
Period covered - end date: 30/6/2021
Project's coordinator: Gabriela S. Lorite Yrjänä, University of Oulu
NMBU contract: Achim Kohler


The MIRACLE project joins 13 European partners from 6 countries and is coordinated by the University of Oulu. MIRACLE will implement and demonstrate an easy-to-operate mid-infrared (MIR) imaging-probe to be used during arthroscopic surgery enabling in-depth diagnosis of articular cartilage. In current clinical practice, the articular cartilage assessment during arthroscopic surgery is solely based by visual inspection and manual probing of the cartilage tissue, which is highly subjective and of poor repeatability. MIRACLE will enable the in vivo accurate evaluation of the biochemical status and composition of articular cartilage, thus assisting the orthopedic surgeon in more objective decision making during the surgery.

BioSpec group at NMBU contributes to the project with multivariate data analysis and spectral pre-processing, for the establishment of multivariate discriminant models to distinguish between healthy and unhealthy tissue conditions.

 

.

Photo
.

.

Photo
.

 

This project received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 780598.
The project is an initiative of the Photonics Public Private Partnership.

Published 2. June 2018 - 14:48 - Updated 18. November 2019 - 11:28